 SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 GLOBE NEWSWIRE -- Vera Therapeutics, Inc. Nasdaq: VERA, a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that Marshall Fordyce, MD, Founder and Chief Executive Officer, will present and participate in one-on-one investor meetings at several upcoming investor conferences in November. Details of these presentations and associated conferences can be found below: 